Get started
Author

Rafael Balsini Barreto

Observed names: Barreto, Rafael Balsini, R.B. Barreto
ORCID: 0009-0008-2134-0422
Observed ORCID: 0009-0008-2134-0422
OpenAlex ID: A5033554585
Pembrolizumab Plus Chemotherapy Versus Chemotherapy as Perioperative Therapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer: Final Analysis of the Randomized, Phase III KEYNOTE-585 Study
2025 · Kohei Shitara, Sun Young Rha, et al. · Journal of Clinical Oncology · 91
Tabagismo entre pacientes internados em um hospital universitário no sul do Brasil: prevalência, grau de dependência e estágio motivacional
2012 · Rafael Balsini Barreto, Mariângela Pimental Pincelli, et al. · Jornal Brasileiro de Pneumologia · 17
PDF
New Oncologic Drugs from 2008 to 2023—Differences in Approval and Access between the United States, Europe and Brazil
2024 · Rafael Balsini Barreto, Andressa Moretti Izidoro, et al. · Current Oncology · 5
PDF
Review of All Solid Tumor Drug Approvals From 2019 to 2024 by US Food and Drug Administration, European Medicines Agency, and Brazilian Health Regulatory Agency
2025 · Rafael Balsini Barreto, Mário Henrique Furlanetto Miranda, et al. · JCO Global Oncology · 4
PDF
Assessing the clinical readiness of the SERENA-6 strategy
2025 · Rafael Balsini Barreto · The Oncologist · 2
PDF
Radiotherapy for Brain Metastases Near the End of Life: Characterizing Patients and Tumor Features
2023 · Saulo Brito Silva, Rafael Balsini Barreto, et al. · JCO Global Oncology · 2
PDF
Impact of Body Mass Index (BMI) on Survival of Breast Cancer Patients Undergoing Endocrine Therapy: Data from a Public Center in Southern Brazil
2026 · Bárbara Andressa Uliana, Andressa Moretti Izidoro, et al. · Brazilian Journal of Oncology
Discrepancies in therapeutic indications for the same oncology drugs among FDA, EMA, and Brazilian agency.
2024 · Camila Marchi Blatt, Mario Henrique Furlanetto Miranda, et al. · Journal of Clinical Oncology
1713P Non-inferiority oncology clinical trials in major journals: Purposes, methods and results
2023 · R.B. Barreto, M.H. Furlanetto Miranda, et al. · Annals of Oncology
PDF
PP.27 Clinical Outcomes of Stage III Non-small Cell Lung Cancer Patients Treated With Radical Radiotherapy in a Institution in Brazil
2023 · Denize Bodnar, Mariana Campos Bomfim, et al. · Journal of Thoracic Oncology
PDF
Radiotherapy for Brain Metastases Near the End of Life
2022 · Fernanda Cristina Gonçalves de Oliveira, Gabriela Schmidt Defende Martin, et al. · Brazilian Journal of Oncology
A Real-world Effectiveness of Perioperative Flot Regimen in Gastric Cancer
2021 · Saulo Brito Silva, Fernanda Cristina Gonçalves Oliveira, et al. · Brazilian Journal of Oncology
NEW ANTICANCER DRUGS FOR SOLID TUMORS IN THE LAST 10 YEARS: DIFFERENCES IN APPROVAL AND ACCESS BETWEEN THE UNITED STATES AND BRAZIL IN THE PUBLIC AND PRIVATE SECTORS. Authors: RAFAEL BALSINI BARRETO (CENTRO DE PESQUISAS ONCOLOGICAS - CEPON - FLORIANÓPOLIS - Santa Catarina - Brasil), ANDRESSA MORETTI IZIDORO (CENTRO DE PESQUISAS ONCOLOGICAS - CEPON - FLORIANÓPOLIS - Santa Catarina - Brasil), SAULO BRITO SILVA (FACULDADE DE MEDICINA DE RIBEIRÃO PRETO - UNIVERSIDADE DE SÃO PAULO - RIBEIRÃO PRETO - São Paulo - Brasil)
2021 · Rafael Balsini Barreto, Andressa Moretti Izidoro, et al. · Brazilian Journal of Oncology
Prevalence and Molecular Profile of Kras Mutation in Patients With Metastatic Non-small Cell Lung Cancer From an Oncology Reference Center in South of Brazil
2021 · Alana Beatriz Tomaselli Visentainer, Carolina Dutra, et al. · Brazilian Journal of Oncology
Works count: 15
Citation count: 121
H-index: 4
I10-index: 2
Year
Topic
Type